Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Jazz Pharma Plc (NQ: JAZZ )

121.49 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13
Open 121.49
Bid (Size) 48.60 (2)
Ask (Size) 124.75 (10)
Prev. Close 121.49
Today's Range 121.49 - 121.49
52wk Range 111.25 - 160.96
Shares Outstanding 62,311,104
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Australian MPs Admit They Tried Cannabis, Signaling Policy Reform & Epidiolex For Seizures Approved In Canada
Around 8% of Australians are using medical marijuana either occasionally or regularly, according to a recent survey of 1,000 participants conducted by consumer insights company Antenna, reported... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Analyst Ratings for Jazz Pharmaceuticals
Via Benzinga

Performance

YTD
-22.30%
-22.30%
1 Month
-8.51%
-8.51%
3 Month
-12.56%
-12.56%
6 Month
-5.76%
-5.76%
1 Year
-19.53%
-19.53%

More News

Read More
3 Top-Rated Biotech Stocks That Analysts Are Loving Now
Via InvestorPlace
Pot Stocks: Values Or Traps?
Via Talk Markets
Topics Cannabis
Exposures Cannabis
3 Biotech Stocks That Could Be Millionaire Makers
Via The Motley Fool
Jazz Pharmaceuticals: Q3 Earnings Insights
Via Benzinga
Where Jazz Pharmaceuticals Stands With Analysts
Via Benzinga
Police Boss Turned Cannabis Reform Advocate, MMJ Legalization In Japan And More Global Updates
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 No-Brainer Stocks to Buy With $200 Right Now
Via The Motley Fool
Autifony Announces Exclusive Global License and Collaboration Agreement with Jazz Pharmaceuticals on Two Ion Channel Targets for Neurological Disorders
From Autifony Therapeutics Ltd
Via Business Wire
7 Healthcare Stocks That Are Poised to Become the Next Unicorns
Via InvestorPlace
Cannabis Cash Burn Concerns? Sell These 7 Overbought Stocks Now.
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
FDA Report On Its 50 Years In Cannabis Research, Signals A Boost In Medical Marijuana Prospects
Via Benzinga
Topics Cannabis
Exposures Cannabis Product Safety
Ireland Reimburses Medical Marijuana-Based Drug For Chemotherapy-Induced Nausea And Vomiting
Via Benzinga
Topics Cannabis
Exposures Cannabis
Global Cancer Vaccines Market Share Is Expected To Reach $19.27 Billion By 2030
Via FinancialNewsMedia
Europe's High: UK Parents Need NHS Help For Daughter's Seizures, THC MMJ Flowers In Switzerland & More
Via Benzinga
Topics Cannabis Supply Chain
Exposures Cannabis Supply Chain
Cannabis Stocks Dip: How Rising Interest Rates Impact Your Portfolio
Via Benzinga
Topics Cannabis
Exposures Cannabis
Europe's High: Irish GPs Against Pot, Switzerland-Spain Share Data On Cannabis Clubs & More
Via Benzinga
Topics Cannabis
Exposures Cannabis
Jazz Pharmaceuticals Explores Asset Sale Option, Possibly Cannabinoid Business: Report
Via Benzinga
2 Top Biotech Stocks to Buy in October
Via The Motley Fool
5 Genius Safe Stocks to Buy for the 4th Quarter of 2023
Via The Motley Fool
4 Perfect Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
Via The Motley Fool
Topics Stocks
Exposures US Equities
3 Cannabis Stocks That Should Be on Every Investor’s Radar This Fall
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Revolutionary Cancer Treatment Advances Promise Brighter Future Amid Federal Funding Uncertainty
Via FinancialNewsMedia
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.